Type 2 diabetes and HbA1c goal: time for individualised therapy.

Jabbour S. Type 2 diabetes and HbA1c goal: time for individualised therapy. Int J Clin Pract. 2009 Oct; 63(10):1408-9.

View in: PubMed

Clinical Trials as Topic
Diabetes Mellitus, Type 2
Diabetic Angiopathies
Humans
Hyperglycemia
Precision Medicine
Risk Factors

Serge Jabbour

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement